Compile Data Set for Download or QSAR
maximum 50k data
Found 231 Enz. Inhib. hit(s) with all data for entry = 9587
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475978(US10865208, Compound I-36 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476097(US10865208, Compound I-152 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475984(US10865208, Compound I-42 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475988(US10865208, Compound I-46 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475992(US10865208, Compound I-50 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475999(US10865208, Compound I-56 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476001(US10865208, Compound I-58 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476005(US10865208, Compound I-62 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476008(US10865208, Compound I-65 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476012(US10865208, Compound I-69 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476022(US10865208, Compound I-79 | [(2R,3S,4R,5R)-5-(4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476032(US10865208, Compound I-89 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476046(US10865208, Compound I-103 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476056(US10865208, Compound I-113 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476057(US10865208, Compound I-114 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476061(US10865208, Compound I-118 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476092(US10865208, Compound I-147 | {(2R,3R,4S,5R)-5-[4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476093(US10865208, Compound I-148 | [(2R,3R,4S,5R)-5-{4-a...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475982(US10865208, Compound I-40 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50: <20nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475954(US10865208, Compound I-13 | [(2R,3S,4R,5R)-5-(4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475969(US10865208, Compound I-27 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475973(US10865208, Compound I-31 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475974(US10865208, Compound I-32 | [(2R,3S,4R,5R)-5-(4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475975(US10865208, Compound I-33 | [(2R,3S,4R,5R)-5-(4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475977(US10865208, Compound I-35 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475980(US10865208, Compound I-38 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475981(US10865208, Compound I-39 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475983(US10865208, Compound I-41 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475985(US10865208, Compound I-43 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475986(US10865208, Compound I-44 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475987(US10865208, Compound I-45 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475993(US10865208, Compound I-51 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475994(US10865208, Compound I-52 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475995(US10865208, Compound I-53 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM475996(US10865208, Compound I-54 | [(2R,3S,4R,5R)-5-(4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476002(US10865208, Compound I-59 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476004(US10865208, Compound I-61 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476006(US10865208, Compound I-63 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476007(US10865208, Compound I-64 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476009(US10865208, Compound I-66 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476016(US10865208, Compound I-73 | [(2R,3S,4R,5R)-5-(4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476020(US10865208, Compound I-77 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476021(US10865208, Compound I-78 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476025(US10865208, Compound I-82 | {(2R,3S,4R,5R)-5-[4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476026(US10865208, Compound I-83 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476028(US10865208, Compound I-85 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476031(US10865208, Compound I-88 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476033(US10865208, Compound I-90 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476034(US10865208, Compound I-91 | [(2R,3S,4R,5R)-5-{4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476040(US10865208, Compound I-97 | [(2R,3R,4S,5R)-5-(4-am...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 231 total ) | Next | Last >>
Jump to: